Literature DB >> 6824787

Characterization of normal peripheral blood lymphocyte colony-forming cells: cell cycle status, surface markers, and cellular growth requirements.

R Taetle, D To, A Caviles, S W Norby, J Mendelsohn.   

Abstract

We performed a series of studies to further clarify the nature of lymphocyte colony-forming cells (CFC) from normal peripheral blood. Mononuclear cells were separated into E-rosette-enriched (E+) and E-rosette-depleted (E-) populations and cultured in methylcellulose with conditioned media and irradiated mononuclear cells. Linear plating relationships were obtained with plating efficiencies of 0.26% +/- .02% (mean +/- SE) for E+ CFC and 0.18% +/- .02% for E- CFC. Cells in E+ colonies were T lymphocytes and in E- colonies were B lymphocytes as determined by cell surface marker analysis. Using the thymidine suicide technique, approximately one-half of CFC were found to be in cycle at any moment, and plating efficiencies and cell cycle status of E+ CFC were not changed by preincubation with PHA in liquid culture for 48 hr. Using antibody complement-mediated cytotoxicity, E+ CFC were found to be T101+, OKT3+, and Ia-, while E- CFC were OKT3- and Ia+. Using monocyte-depleted populations obtained by sedimentation at unit gravity, lymphocyte colony growth was absent in monocyte-depleted fractions, and optimal growth occurred with 40% monocytes in culture. In contrast to some previous studies, we find that lymphocyte CFC originate from a small, cycling population of cells bearing mature T or B lymphocyte markers. Entry into cell division, however, does not confer colony-forming capacity on lymphocytes. Monocytes are critical to growth of E+ CFC, and cultures severely depleted of monocytes would not be expected to form colonies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824787

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors:  B P Ram; P Tyle
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

2.  Origin of T lymphocyte colony-forming cells in cell populations depleted of sheep erythrocyte rosette forming cells.

Authors:  C Roy; C A Izaguirre
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

Review 3.  Human B cell colony assays.

Authors:  J C Kluin-Nelemans; R Willemze
Journal:  Blut       Date:  1987-10

4.  Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.

Authors:  R Taetle; K Rhyner; J Castagnola; D To; J Mendelsohn
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.

Authors:  T Suzawa; S Hyodo; T Kishi; H Kashiwa; T Karakawa; E Kittaka; T Sakano; T Usui
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

6.  Bone marrow T cell colony-forming cells: studies of their origin and use in monitoring T cell-depleted bone marrow grafts.

Authors:  L J Knott; R J Levinsky; A C Newland; H M Jones; D C Linch
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.